198 related articles for article (PubMed ID: 9772328)
1. Concomitant vaccination against hepatitis A and typhoid fever.
Van Hoecke C; Lebacq E; Beran J; Prymula R; Collard F
J Travel Med; 1998 Sep; 5(3):116-20. PubMed ID: 9772328
[TBL] [Abstract][Full Text] [Related]
2. A single dose, combined vaccine against typhoid fever and hepatitis A: consistency, immunogenicity and reactogenicity.
Beran J; Beutels M; Levie K; Van Damme P; Dieussaert I; Gillet M; Van Hoecke C; Tornieporth N
J Travel Med; 2000; 7(5):246-52. PubMed ID: 11231208
[TBL] [Abstract][Full Text] [Related]
3. A randomized, open-label study of the immunogenicity and reactogenicity of three lots of a combined typhoid fever/hepatitis A vaccine in healthy adults.
Loebermann M; Kollaritsch H; Ziegler T; Rendi-Wagner P; Chambonneau L; Dumas R; Lafrenz M
Clin Ther; 2004 Jul; 26(7):1084-91. PubMed ID: 15336473
[TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of a new inactivated hepatitis A vaccine in concurrent administration with a typhoid fever vaccine or a typhoid fever + yellow fever vaccine.
Dumas R; Forrat R; Lang J; Farinelli T; Loutan L
Adv Ther; 1997; 14(4):160-7. PubMed ID: 10174195
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.
Bhutta ZA; Capeding MR; Bavdekar A; Marchetti E; Ariff S; Soofi SB; Anemona A; Habib MA; Alberto E; Juvekar S; Khan RM; Marhaba R; Ali N; Malubay N; Kawade A; Saul A; Martin LB; Podda A
Lancet Infect Dis; 2014 Feb; 14(2):119-29. PubMed ID: 24290843
[TBL] [Abstract][Full Text] [Related]
6. Combined vaccination against hepatitis A, hepatitis B, and typhoid fever: safety, reactogenicity, and immunogenicity.
Proell S; Maiwald H; Nothdurft HD; Saenger R; Vollmar J; De Clercq N; von Sonnenburg F
J Travel Med; 2002; 9(3):122-6. PubMed ID: 12088576
[TBL] [Abstract][Full Text] [Related]
7. Comparison of immunogenicity of two hepatitis A vaccines--VAQTA and HAVRIX--in young adults.
Ashur Y; Adler R; Rowe M; Shouval D
Vaccine; 1999 May; 17(18):2290-6. PubMed ID: 10403597
[TBL] [Abstract][Full Text] [Related]
8. Reactogenicity and immunogenicity of a single dose of typhoid Vi polysaccharide vaccine in children aged between 4 and 14 years.
Pelser HH
BioDrugs; 2001; 15 Suppl 1():13-9. PubMed ID: 11754631
[TBL] [Abstract][Full Text] [Related]
9. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
[TBL] [Abstract][Full Text] [Related]
10. A phase 1 randomized safety, reactogenicity, and immunogenicity study of Typhax: A novel protein capsular matrix vaccine candidate for the prevention of typhoid fever.
Cartee RT; Thanawastien A; Griffin Iv TJ; Mekalanos JJ; Bart S; Killeen KP
PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007912. PubMed ID: 31905228
[TBL] [Abstract][Full Text] [Related]
11. A Japanese study to assess immunogenicity and safety of a typhoid Vi polysaccharide vaccine.
Miyazu M; Kikuchi H; Hamada A; Fukushima S; Ouchi K; Bosch Castells V; Mihara H; Bonnet MC
Vaccine; 2015 Nov; 33(48):6697-702. PubMed ID: 26518404
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and children.
Capeding MR; Teshome S; Saluja T; Syed KA; Kim DR; Park JY; Yang JS; Kim YH; Park J; Jo SK; Chon Y; Kothari S; Yang SY; Ham DS; Ryu JH; Hwang HS; Mun JH; Lynch JA; Kim JH; Kim H; Excler JL; Sahastrabuddhe S
Vaccine; 2018 Jun; 36(26):3794-3801. PubMed ID: 29776750
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the reactogenicity and immunogenicity of two different dose levels of hepatitis A vaccine in healthy children and adolescents.
Poovorawan Y; Kosuwon P; Sutra S; Theamboonlers A; Vimolket T; Safary A
Asian Pac J Allergy Immunol; 1998; 16(2-3):111-7. PubMed ID: 9876949
[TBL] [Abstract][Full Text] [Related]
14. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children.
Kanra G; Yalçin SS; Ceyhan M; Yurdakök K
Turk J Pediatr; 2000; 42(2):105-8. PubMed ID: 10936974
[TBL] [Abstract][Full Text] [Related]
15. Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence.
Van Damme P; Thoelen S; Cramm M; De Groote K; Safary A; Meheus A
J Med Virol; 1994 Dec; 44(4):446-51. PubMed ID: 7897379
[TBL] [Abstract][Full Text] [Related]
16. Reactogenicity and immunogenicity of a single dose of a typhoid Vi polysaccharide vaccine in adolescents.
Ramkissoon A; Jugnundan P
BioDrugs; 2001; 15 Suppl 1():21-6. PubMed ID: 11754632
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and safety of Vi capsular polysaccharide typhoid vaccine in healthy persons in Korea.
Lim SM; Jung HS; Kim MJ; Park DW; Kim WJ; Cheong HJ; Park SC; Lee KC; Shin YK; Tan HK; Kim SL; Sohn JW
J Microbiol Biotechnol; 2007 Apr; 17(4):611-5. PubMed ID: 18051272
[TBL] [Abstract][Full Text] [Related]
18. Revaccination with locally-produced vi typhoid polysaccharide vaccine among chinese school-aged children: safety and immunogenicity findings.
Zhou WZ; Koo HW; Wang XY; Zhang J; Park JK; Zhu F; Deen J; Acosta CJ; Chen Y; Wang H; Galindo CM; Ochiai L; Park T; von Seidlein L; Xu ZY; Clemens JD
Pediatr Infect Dis J; 2007 Nov; 26(11):1001-5. PubMed ID: 17984806
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph™) in Indian children: School based cluster randomized study.
Mitra M; Shah N; Ghosh A; Chatterjee S; Kaur I; Bhattacharya N; Basu S
Hum Vaccin Immunother; 2016 Apr; 12(4):939-45. PubMed ID: 26901576
[TBL] [Abstract][Full Text] [Related]
20. Combined typhoid fever and hepatitis A vaccine: comparison of immunogenicity and safety to concomitant monovalent vaccine over 3 years.
Overbosch D; Peyron F; Picot N; Varichon JP; Dumas R; Chambonneau L; Weber F
J Travel Med; 2005; 12(6):319-26. PubMed ID: 16343383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
